AR109064A2 - SOLID PHARMACEUTICAL COMPOSITION FORMULATED UNDER A UNIT DOSAGE FORM CONTAINING A DIPEPTIDIL PEPTIDASA INHIBITOR - Google Patents
SOLID PHARMACEUTICAL COMPOSITION FORMULATED UNDER A UNIT DOSAGE FORM CONTAINING A DIPEPTIDIL PEPTIDASA INHIBITORInfo
- Publication number
- AR109064A2 AR109064A2 ARP170101976A ARP170101976A AR109064A2 AR 109064 A2 AR109064 A2 AR 109064A2 AR P170101976 A ARP170101976 A AR P170101976A AR P170101976 A ARP170101976 A AR P170101976A AR 109064 A2 AR109064 A2 AR 109064A2
- Authority
- AR
- Argentina
- Prior art keywords
- dosage form
- unit dosage
- solid pharmaceutical
- pharmaceutical composition
- inhibitor
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Composiciones farmacéuticas sólidas formuladas bajo una forma de dosificación unitaria, donde dicha forma de dosificación unitaria comprende entre 1 mg y 250 mg del compuesto de fórmula (1), y un vehículo farmacéuticamente aceptable. Reivindicación 12: La composición farmacéutica sólida acorde con cualquiera de las reivindicaciones 1 - 11, caracterizada porque dicha forma de dosificación unitaria comprende además un compuesto antidiabético distinto al compuesto de fórmula (1) que se selecciona del grupo que consiste en entre 125 mg y 2250 mg de metformina y entre 7,5 mg y 60 mg de pioglitazona. Reivindicación 18: La composición farmacéutica sólida acorde con cualquiera de las reivindicaciones 1 - 17, caracterizada porque se utiliza para tratar la diabetes Tipo I o Tipo II.Solid pharmaceutical compositions formulated under a unit dosage form, wherein said unit dosage form comprises between 1 mg and 250 mg of the compound of formula (1), and a pharmaceutically acceptable carrier. Claim 12: The solid pharmaceutical composition according to any of claims 1-11, characterized in that said unit dosage form further comprises an antidiabetic compound other than the compound of formula (1) which is selected from the group consisting of between 125 mg and 2250 mg of metformin and between 7.5 mg and 60 mg of pioglitazone. Claim 18: The solid pharmaceutical composition according to any of claims 1-17, characterized in that it is used to treat Type I or Type II diabetes.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71756005P | 2005-09-14 | 2005-09-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR109064A2 true AR109064A2 (en) | 2018-10-24 |
Family
ID=50831057
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP170101976A AR109064A2 (en) | 2005-09-14 | 2017-07-14 | SOLID PHARMACEUTICAL COMPOSITION FORMULATED UNDER A UNIT DOSAGE FORM CONTAINING A DIPEPTIDIL PEPTIDASA INHIBITOR |
Country Status (3)
| Country | Link |
|---|---|
| AR (1) | AR109064A2 (en) |
| JO (1) | JO3254B1 (en) |
| UA (1) | UA93689C2 (en) |
-
2006
- 2006-09-13 UA UAA200804056A patent/UA93689C2/en unknown
- 2006-09-13 JO JOP/2006/0309A patent/JO3254B1/en active
-
2017
- 2017-07-14 AR ARP170101976A patent/AR109064A2/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JO3254B1 (en) | 2018-09-16 |
| UA93689C2 (en) | 2011-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20070583A1 (en) | FORMULATION INCLUDING A DIPEPTIDYL-PEPTIDASE IV INHIBITOR AND METFORMIN | |
| ECSP055867A (en) | PIRROLOPIRIMIDINE DERIVATIVES | |
| AR052853A1 (en) | ORAL COMPOSITIONS CONTAINING ANTIBACTERIAL BIFENOL COMPOUNDS | |
| RS53155B (en) | Administration of dipeptidyl peptidase inhibitors | |
| DE602004008098D1 (en) | SUBSTITUTED 2H-Ä1,2,4ÜTRIAZOLOÄ4,3-AÜPYRAZINE AS GSK-3 INHIBITORS | |
| AR056873A1 (en) | DERIVATIVES OF PIRAZOLOPIRIMIDINAS AS QUINASA INHIBITORS OF CYCLINE DEPENDENTS, PHARMACEUTICAL COMPOSITIONS | |
| AR049274A1 (en) | ACID2 - {[2- (2-METHYLAMINOPIRIMIDIN-4-IL) -1H-INDOL-5-CARBONYL] AMINO} -3- (PHENYLPIRIDIN-2-ILAMINO) SUBSTANTIALLY PURE PROPIONIC AS A SELECTIVE KINASE IKK-2 INHIBITOR | |
| DOP2006000170A (en) | NEW DERIVATIVES OF ESPIROCROMANONA | |
| AR039936A1 (en) | PHARMACEUTICAL FORMULATION OF MODIFIED LIBERATION | |
| NO20070224L (en) | 2-urea-4-phenylthiazole derivatives, preparation and therapeutic use thereof | |
| AR053412A1 (en) | INHIBITING COMPOUNDS OF INTERACTION BETWEEN MDM2 AND P53, A METHOD OF PREPARATION, PHARMACEUTICAL COMPOSITION AND USE OF THE COMPOUND TO MANUFACTURE MEDICATIONS | |
| CU20100200A7 (en) | A PHARMACEUTICAL COMPOSITION THAT INCLUDES N- (3,4-DIFLUORO-2-4-IODOFENILAMINO) -6-METOXIFENIL) -L- (2,3-DIHIDROXIPROPIL) CICLOPROPANO-L-SULFONAMIDE, USEFUL FOR THE TREATMENT AND PREVENTION OF CANNER OF INFLAMMATORY DISEASES | |
| CO6321225A2 (en) | SOLID CARRIER PARTICLES TO IMPROVE THE PROCESSABILITY OF A PHARMACEUTICAL AGENT | |
| AR082825A2 (en) | HITEROCICLIC INHIBITORS NITROGENATED FROM MEK, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, METHODS TO PREPARE THEM AND USE OF THE SAME FOR THE TREATMENT OF HYPERPROLIFERATIVE OR INFLAMMATORY DISORDERS | |
| RU2008139905A (en) | PHARMACEUTICAL COMPOSITION FOR EXTERNAL USE | |
| SV2008001369A (en) | BENZIMIDAZOLES | |
| UY30819A1 (en) | DERIVATIVES OF PIRAZOL, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCESSES AND APPLICATIONS | |
| EA200501268A1 (en) | HIV-Inhibiting 1,2,4-TRIAZINS | |
| EA200901277A1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING DAPAGLYFLOSINE PROPYLENE GLYCOLHYDRATE | |
| AR033359A1 (en) | AMIDINE COMPOUND, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT TO INHIBIT THE SYNTHESIS OF NITRIC OXIDE | |
| AR049681A1 (en) | MACROLIDS PREPARED FROM ACTINOMICETS. PHARMACEUTICAL COMPOSITIONS | |
| AR057162A1 (en) | BENZAMIDE COMPOUNDS AS INHIBITORS OF THE ENZYME HISTONA DEACETILASE (HDAC) | |
| CO5710195A1 (en) | ALFA CRYSTALLINE FORM OF THE STRONIC RANELATE, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT | |
| UY29169A1 (en) | DERIVATIVES OF 2-AMIDO-4 FENILTIAZOL, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS | |
| UY28979A1 (en) | DERIVATIVES OF 3-CARBOXAMIDE HYDROCLORURES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCEDURE AND ITS USE, USED AS SELECTED INHIBITORS OF GSK3 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |